Literature DB >> 24974350

Synthesis and structure-activity relationships of guaiane-type sesquiterpene lactone derivatives with respect to inhibiting NO production in lipopolysaccharide-induced RAW 264.7 macrophages.

Hao Chen1, Bing-Yang Chen2, Chun-Ting Liu2, Zeng Zhao2, Wen-Hao Shao2, Hu Yuan3, Kai-Jian Bi2, Jiang-Yun Liu4, Qing-Yan Sun5, Wei-Dong Zhang6.   

Abstract

A guaiane framework was scaffolded by photochemical rearrangement reactions using α-santonin 1 as a starting material. Then, using a series of reactions, we synthesized the guaiane-type sesquiterpene lactone 5 in high yield. The inhibitory activities of compound 5 and of a series of derivatives on nitric oxide (NO) release were evaluated in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Compounds 6g, 7h, 7i, 7k and 8g, exhibited significant inhibitory effects on NO production, with IC50 values of 14.8, 22.3, 18.3, 17.4 and 7.0 μM, respectively. Their cytotoxicities were also estimated using an MTT assay. The structure-activity relationships of these compounds were also discussed.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Guaiane-type derivatives; Inhibitory effect; Nitric oxide production; Structure–activity relationship

Mesh:

Substances:

Year:  2014        PMID: 24974350     DOI: 10.1016/j.ejmech.2014.06.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Naturally occurring sesquiterpene lactones and their semi-synthetic derivatives modulate PGE2 levels by decreasing COX2 activity and expression.

Authors:  Filomena Perri; Luca Frattaruolo; Ian Haworth; Matteo Brindisi; Asma El-magboub; Angela Ferrario; Charles Gomer; Francesca Aiello; James David Adams
Journal:  Heliyon       Date:  2019-03-27

2.  Xylopins A-F, six rare guaiane dimers with three different connecting modes from Xylopia vielana.

Authors:  Yang-Guo Xie; Rong Yan; Xianglong Zhong; Huang Piao; Ishaq Muhammad; Xisong Ke; Shikai Yan; Yuanqiang Guo; Hui-Zi Jin; Wei-Dong Zhang
Journal:  RSC Adv       Date:  2019-03-21       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.